Global Rotavirus Infections Drug Market Insights and Forecast to 2031

Report ID: 1564004 | Published Date: Jan 2025 | No. of Page: 97 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Rotavirus Infections Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global Rotavirus Infections Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 RV-3BB
        1.2.3 RV-625
        1.2.4 UMN-2001
        1.2.5 Rotavac-5C
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Rotavirus Infections Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Rotavirus Infections Drug Sales Estimates and Forecasts 2017-2028
    2.2 Global Rotavirus Infections Drug Revenue Estimates and Forecasts 2017-2028
    2.3 Global Rotavirus Infections Drug Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Rotavirus Infections Drug Sales by Region
        2.4.1 Global Rotavirus Infections Drug Sales by Region (2017-2022)
        2.4.2 Global Sales Rotavirus Infections Drug by Region (2023-2028)
    2.5 Global Rotavirus Infections Drug Revenue by Region
        2.5.1 Global Rotavirus Infections Drug Revenue by Region (2017-2022)
        2.5.2 Global Rotavirus Infections Drug Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Rotavirus Infections Drug Sales by Manufacturers
        3.1.1 Global Top Rotavirus Infections Drug Manufacturers by Sales (2017-2022)
        3.1.2 Global Rotavirus Infections Drug Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rotavirus Infections Drug in 2021
    3.2 Global Rotavirus Infections Drug Revenue by Manufacturers
        3.2.1 Global Rotavirus Infections Drug Revenue by Manufacturers (2017-2022)
        3.2.2 Global Rotavirus Infections Drug Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Rotavirus Infections Drug Revenue in 2021
    3.3 Global Rotavirus Infections Drug Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Rotavirus Infections Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Rotavirus Infections Drug Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Rotavirus Infections Drug Sales by Type
        4.1.1 Global Rotavirus Infections Drug Historical Sales by Type (2017-2022)
        4.1.2 Global Rotavirus Infections Drug Forecasted Sales by Type (2023-2028)
        4.1.3 Global Rotavirus Infections Drug Sales Market Share by Type (2017-2028)
    4.2 Global Rotavirus Infections Drug Revenue by Type
        4.2.1 Global Rotavirus Infections Drug Historical Revenue by Type (2017-2022)
        4.2.2 Global Rotavirus Infections Drug Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Rotavirus Infections Drug Revenue Market Share by Type (2017-2028)
    4.3 Global Rotavirus Infections Drug Price by Type
        4.3.1 Global Rotavirus Infections Drug Price by Type (2017-2022)
        4.3.2 Global Rotavirus Infections Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Rotavirus Infections Drug Sales by Application
        5.1.1 Global Rotavirus Infections Drug Historical Sales by Application (2017-2022)
        5.1.2 Global Rotavirus Infections Drug Forecasted Sales by Application (2023-2028)
        5.1.3 Global Rotavirus Infections Drug Sales Market Share by Application (2017-2028)
    5.2 Global Rotavirus Infections Drug Revenue by Application
        5.2.1 Global Rotavirus Infections Drug Historical Revenue by Application (2017-2022)
        5.2.2 Global Rotavirus Infections Drug Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Rotavirus Infections Drug Revenue Market Share by Application (2017-2028)
    5.3 Global Rotavirus Infections Drug Price by Application
        5.3.1 Global Rotavirus Infections Drug Price by Application (2017-2022)
        5.3.2 Global Rotavirus Infections Drug Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Rotavirus Infections Drug Market Size by Type
        6.1.1 North America Rotavirus Infections Drug Sales by Type (2017-2028)
        6.1.2 North America Rotavirus Infections Drug Revenue by Type (2017-2028)
    6.2 North America Rotavirus Infections Drug Market Size by Application
        6.2.1 North America Rotavirus Infections Drug Sales by Application (2017-2028)
        6.2.2 North America Rotavirus Infections Drug Revenue by Application (2017-2028)
    6.3 North America Rotavirus Infections Drug Market Size by Country
        6.3.1 North America Rotavirus Infections Drug Sales by Country (2017-2028)
        6.3.2 North America Rotavirus Infections Drug Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Rotavirus Infections Drug Market Size by Type
        7.1.1 Europe Rotavirus Infections Drug Sales by Type (2017-2028)
        7.1.2 Europe Rotavirus Infections Drug Revenue by Type (2017-2028)
    7.2 Europe Rotavirus Infections Drug Market Size by Application
        7.2.1 Europe Rotavirus Infections Drug Sales by Application (2017-2028)
        7.2.2 Europe Rotavirus Infections Drug Revenue by Application (2017-2028)
    7.3 Europe Rotavirus Infections Drug Market Size by Country
        7.3.1 Europe Rotavirus Infections Drug Sales by Country (2017-2028)
        7.3.2 Europe Rotavirus Infections Drug Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Rotavirus Infections Drug Market Size by Type
        8.1.1 Asia Pacific Rotavirus Infections Drug Sales by Type (2017-2028)
        8.1.2 Asia Pacific Rotavirus Infections Drug Revenue by Type (2017-2028)
    8.2 Asia Pacific Rotavirus Infections Drug Market Size by Application
        8.2.1 Asia Pacific Rotavirus Infections Drug Sales by Application (2017-2028)
        8.2.2 Asia Pacific Rotavirus Infections Drug Revenue by Application (2017-2028)
    8.3 Asia Pacific Rotavirus Infections Drug Market Size by Region
        8.3.1 Asia Pacific Rotavirus Infections Drug Sales by Region (2017-2028)
        8.3.2 Asia Pacific Rotavirus Infections Drug Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Rotavirus Infections Drug Market Size by Type
        9.1.1 Latin America Rotavirus Infections Drug Sales by Type (2017-2028)
        9.1.2 Latin America Rotavirus Infections Drug Revenue by Type (2017-2028)
    9.2 Latin America Rotavirus Infections Drug Market Size by Application
        9.2.1 Latin America Rotavirus Infections Drug Sales by Application (2017-2028)
        9.2.2 Latin America Rotavirus Infections Drug Revenue by Application (2017-2028)
    9.3 Latin America Rotavirus Infections Drug Market Size by Country
        9.3.1 Latin America Rotavirus Infections Drug Sales by Country (2017-2028)
        9.3.2 Latin America Rotavirus Infections Drug Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Rotavirus Infections Drug Market Size by Type
        10.1.1 Middle East and Africa Rotavirus Infections Drug Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Rotavirus Infections Drug Revenue by Type (2017-2028)
    10.2 Middle East and Africa Rotavirus Infections Drug Market Size by Application
        10.2.1 Middle East and Africa Rotavirus Infections Drug Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Rotavirus Infections Drug Revenue by Application (2017-2028)
    10.3 Middle East and Africa Rotavirus Infections Drug Market Size by Country
        10.3.1 Middle East and Africa Rotavirus Infections Drug Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Rotavirus Infections Drug Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Beijing Minhai Biotechnology Co Ltd
        11.1.1 Beijing Minhai Biotechnology Co Ltd Corporation Information
        11.1.2 Beijing Minhai Biotechnology Co Ltd Overview
        11.1.3 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Beijing Minhai Biotechnology Co Ltd Recent Developments
    11.2 Bharat Biotech International Ltd
        11.2.1 Bharat Biotech International Ltd Corporation Information
        11.2.2 Bharat Biotech International Ltd Overview
        11.2.3 Bharat Biotech International Ltd Rotavirus Infections Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Bharat Biotech International Ltd Rotavirus Infections Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Bharat Biotech International Ltd Recent Developments
    11.3 Biological E Ltd
        11.3.1 Biological E Ltd Corporation Information
        11.3.2 Biological E Ltd Overview
        11.3.3 Biological E Ltd Rotavirus Infections Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Biological E Ltd Rotavirus Infections Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Biological E Ltd Recent Developments
    11.4 Curevac AG
        11.4.1 Curevac AG Corporation Information
        11.4.2 Curevac AG Overview
        11.4.3 Curevac AG Rotavirus Infections Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Curevac AG Rotavirus Infections Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Curevac AG Recent Developments
    11.5 Medicago Inc
        11.5.1 Medicago Inc Corporation Information
        11.5.2 Medicago Inc Overview
        11.5.3 Medicago Inc Rotavirus Infections Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Medicago Inc Rotavirus Infections Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Medicago Inc Recent Developments
    11.6 Nanotherapeutics Inc
        11.6.1 Nanotherapeutics Inc Corporation Information
        11.6.2 Nanotherapeutics Inc Overview
        11.6.3 Nanotherapeutics Inc Rotavirus Infections Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Nanotherapeutics Inc Rotavirus Infections Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Nanotherapeutics Inc Recent Developments
    11.7 Serum Institute of India Ltd
        11.7.1 Serum Institute of India Ltd Corporation Information
        11.7.2 Serum Institute of India Ltd Overview
        11.7.3 Serum Institute of India Ltd Rotavirus Infections Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Serum Institute of India Ltd Rotavirus Infections Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Serum Institute of India Ltd Recent Developments
    11.8 UMN Pharma Inc
        11.8.1 UMN Pharma Inc Corporation Information
        11.8.2 UMN Pharma Inc Overview
        11.8.3 UMN Pharma Inc Rotavirus Infections Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 UMN Pharma Inc Rotavirus Infections Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 UMN Pharma Inc Recent Developments
    11.9 Wuhan Institute of Biological Products Co Ltd
        11.9.1 Wuhan Institute of Biological Products Co Ltd Corporation Information
        11.9.2 Wuhan Institute of Biological Products Co Ltd Overview
        11.9.3 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Wuhan Institute of Biological Products Co Ltd Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Rotavirus Infections Drug Industry Chain Analysis
    12.2 Rotavirus Infections Drug Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Rotavirus Infections Drug Production Mode & Process
    12.4 Rotavirus Infections Drug Sales and Marketing
        12.4.1 Rotavirus Infections Drug Sales Channels
        12.4.2 Rotavirus Infections Drug Distributors
    12.5 Rotavirus Infections Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Rotavirus Infections Drug Industry Trends
    13.2 Rotavirus Infections Drug Market Drivers
    13.3 Rotavirus Infections Drug Market Challenges
    13.4 Rotavirus Infections Drug Market Restraints
14 Key Findings in The Global Rotavirus Infections Drug Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Rotavirus Infections Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of RV-3BB
    Table 3. Major Manufacturers of RV-625
    Table 4. Major Manufacturers of UMN-2001
    Table 5. Major Manufacturers of Rotavac-5C
    Table 6. Major Manufacturers of Others
    Table 7. Global Rotavirus Infections Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Rotavirus Infections Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Rotavirus Infections Drug Sales by Region (2017-2022) & (K Pcs)
    Table 10. Global Rotavirus Infections Drug Sales Market Share by Region (2017-2022)
    Table 11. Global Rotavirus Infections Drug Sales by Region (2023-2028) & (K Pcs)
    Table 12. Global Rotavirus Infections Drug Sales Market Share by Region (2023-2028)
    Table 13. Global Rotavirus Infections Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Rotavirus Infections Drug Revenue Market Share by Region (2017-2022)
    Table 15. Global Rotavirus Infections Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Rotavirus Infections Drug Revenue Market Share by Region (2023-2028)
    Table 17. Global Rotavirus Infections Drug Sales by Manufacturers (2017-2022) & (K Pcs)
    Table 18. Global Rotavirus Infections Drug Sales Share by Manufacturers (2017-2022)
    Table 19. Global Rotavirus Infections Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Rotavirus Infections Drug Revenue Share by Manufacturers (2017-2022)
    Table 21. Rotavirus Infections Drug Price by Manufacturers (2017-2022) &(USD/Pcs)
    Table 22. Global Rotavirus Infections Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Rotavirus Infections Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rotavirus Infections Drug as of 2021)
    Table 24. Rotavirus Infections Drug Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Rotavirus Infections Drug Product Offered
    Table 26. Date of Manufacturers Enter into Rotavirus Infections Drug Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Rotavirus Infections Drug Sales by Type (2017-2022) & (K Pcs)
    Table 29. Global Rotavirus Infections Drug Sales by Type (2023-2028) & (K Pcs)
    Table 30. Global Rotavirus Infections Drug Sales Share by Type (2017-2022)
    Table 31. Global Rotavirus Infections Drug Sales Share by Type (2023-2028)
    Table 32. Global Rotavirus Infections Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Rotavirus Infections Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Rotavirus Infections Drug Revenue Share by Type (2017-2022)
    Table 35. Global Rotavirus Infections Drug Revenue Share by Type (2023-2028)
    Table 36. Rotavirus Infections Drug Price by Type (2017-2022) & (USD/Pcs)
    Table 37. Global Rotavirus Infections Drug Price Forecast by Type (2023-2028) & (USD/Pcs)
    Table 38. Global Rotavirus Infections Drug Sales by Application (2017-2022) & (K Pcs)
    Table 39. Global Rotavirus Infections Drug Sales by Application (2023-2028) & (K Pcs)
    Table 40. Global Rotavirus Infections Drug Sales Share by Application (2017-2022)
    Table 41. Global Rotavirus Infections Drug Sales Share by Application (2023-2028)
    Table 42. Global Rotavirus Infections Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Rotavirus Infections Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Rotavirus Infections Drug Revenue Share by Application (2017-2022)
    Table 45. Global Rotavirus Infections Drug Revenue Share by Application (2023-2028)
    Table 46. Rotavirus Infections Drug Price by Application (2017-2022) & (USD/Pcs)
    Table 47. Global Rotavirus Infections Drug Price Forecast by Application (2023-2028) & (USD/Pcs)
    Table 48. North America Rotavirus Infections Drug Sales by Type (2017-2022) & (K Pcs)
    Table 49. North America Rotavirus Infections Drug Sales by Type (2023-2028) & (K Pcs)
    Table 50. North America Rotavirus Infections Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Rotavirus Infections Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Rotavirus Infections Drug Sales by Application (2017-2022) & (K Pcs)
    Table 53. North America Rotavirus Infections Drug Sales by Application (2023-2028) & (K Pcs)
    Table 54. North America Rotavirus Infections Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Rotavirus Infections Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Rotavirus Infections Drug Sales by Country (2017-2022) & (K Pcs)
    Table 57. North America Rotavirus Infections Drug Sales by Country (2023-2028) & (K Pcs)
    Table 58. North America Rotavirus Infections Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Rotavirus Infections Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Rotavirus Infections Drug Sales by Type (2017-2022) & (K Pcs)
    Table 61. Europe Rotavirus Infections Drug Sales by Type (2023-2028) & (K Pcs)
    Table 62. Europe Rotavirus Infections Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Rotavirus Infections Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Rotavirus Infections Drug Sales by Application (2017-2022) & (K Pcs)
    Table 65. Europe Rotavirus Infections Drug Sales by Application (2023-2028) & (K Pcs)
    Table 66. Europe Rotavirus Infections Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Rotavirus Infections Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Rotavirus Infections Drug Sales by Country (2017-2022) & (K Pcs)
    Table 69. Europe Rotavirus Infections Drug Sales by Country (2023-2028) & (K Pcs)
    Table 70. Europe Rotavirus Infections Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Rotavirus Infections Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Rotavirus Infections Drug Sales by Type (2017-2022) & (K Pcs)
    Table 73. Asia Pacific Rotavirus Infections Drug Sales by Type (2023-2028) & (K Pcs)
    Table 74. Asia Pacific Rotavirus Infections Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Rotavirus Infections Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Rotavirus Infections Drug Sales by Application (2017-2022) & (K Pcs)
    Table 77. Asia Pacific Rotavirus Infections Drug Sales by Application (2023-2028) & (K Pcs)
    Table 78. Asia Pacific Rotavirus Infections Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Rotavirus Infections Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Rotavirus Infections Drug Sales by Region (2017-2022) & (K Pcs)
    Table 81. Asia Pacific Rotavirus Infections Drug Sales by Region (2023-2028) & (K Pcs)
    Table 82. Asia Pacific Rotavirus Infections Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Rotavirus Infections Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Rotavirus Infections Drug Sales by Type (2017-2022) & (K Pcs)
    Table 85. Latin America Rotavirus Infections Drug Sales by Type (2023-2028) & (K Pcs)
    Table 86. Latin America Rotavirus Infections Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Rotavirus Infections Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Rotavirus Infections Drug Sales by Application (2017-2022) & (K Pcs)
    Table 89. Latin America Rotavirus Infections Drug Sales by Application (2023-2028) & (K Pcs)
    Table 90. Latin America Rotavirus Infections Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Rotavirus Infections Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Rotavirus Infections Drug Sales by Country (2017-2022) & (K Pcs)
    Table 93. Latin America Rotavirus Infections Drug Sales by Country (2023-2028) & (K Pcs)
    Table 94. Latin America Rotavirus Infections Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Rotavirus Infections Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Rotavirus Infections Drug Sales by Type (2017-2022) & (K Pcs)
    Table 97. Middle East and Africa Rotavirus Infections Drug Sales by Type (2023-2028) & (K Pcs)
    Table 98. Middle East and Africa Rotavirus Infections Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Rotavirus Infections Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Rotavirus Infections Drug Sales by Application (2017-2022) & (K Pcs)
    Table 101. Middle East and Africa Rotavirus Infections Drug Sales by Application (2023-2028) & (K Pcs)
    Table 102. Middle East and Africa Rotavirus Infections Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Rotavirus Infections Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Rotavirus Infections Drug Sales by Country (2017-2022) & (K Pcs)
    Table 105. Middle East and Africa Rotavirus Infections Drug Sales by Country (2023-2028) & (K Pcs)
    Table 106. Middle East and Africa Rotavirus Infections Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Rotavirus Infections Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Beijing Minhai Biotechnology Co Ltd Corporation Information
    Table 109. Beijing Minhai Biotechnology Co Ltd Description and Major Businesses
    Table 110. Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 111. Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Beijing Minhai Biotechnology Co Ltd Recent Developments
    Table 113. Bharat Biotech International Ltd Corporation Information
    Table 114. Bharat Biotech International Ltd Description and Major Businesses
    Table 115. Bharat Biotech International Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 116. Bharat Biotech International Ltd Rotavirus Infections Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Bharat Biotech International Ltd Recent Developments
    Table 118. Biological E Ltd Corporation Information
    Table 119. Biological E Ltd Description and Major Businesses
    Table 120. Biological E Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 121. Biological E Ltd Rotavirus Infections Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Biological E Ltd Recent Developments
    Table 123. Curevac AG Corporation Information
    Table 124. Curevac AG Description and Major Businesses
    Table 125. Curevac AG Rotavirus Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 126. Curevac AG Rotavirus Infections Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Curevac AG Recent Developments
    Table 128. Medicago Inc Corporation Information
    Table 129. Medicago Inc Description and Major Businesses
    Table 130. Medicago Inc Rotavirus Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 131. Medicago Inc Rotavirus Infections Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Medicago Inc Recent Developments
    Table 133. Nanotherapeutics Inc Corporation Information
    Table 134. Nanotherapeutics Inc Description and Major Businesses
    Table 135. Nanotherapeutics Inc Rotavirus Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 136. Nanotherapeutics Inc Rotavirus Infections Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Nanotherapeutics Inc Recent Developments
    Table 138. Serum Institute of India Ltd Corporation Information
    Table 139. Serum Institute of India Ltd Description and Major Businesses
    Table 140. Serum Institute of India Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 141. Serum Institute of India Ltd Rotavirus Infections Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Serum Institute of India Ltd Recent Developments
    Table 143. UMN Pharma Inc Corporation Information
    Table 144. UMN Pharma Inc Description and Major Businesses
    Table 145. UMN Pharma Inc Rotavirus Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 146. UMN Pharma Inc Rotavirus Infections Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. UMN Pharma Inc Recent Developments
    Table 148. Wuhan Institute of Biological Products Co Ltd Corporation Information
    Table 149. Wuhan Institute of Biological Products Co Ltd Description and Major Businesses
    Table 150. Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 151. Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Wuhan Institute of Biological Products Co Ltd Recent Developments
    Table 153. Key Raw Materials Lists
    Table 154. Raw Materials Key Suppliers Lists
    Table 155. Rotavirus Infections Drug Distributors List
    Table 156. Rotavirus Infections Drug Customers List
    Table 157. Rotavirus Infections Drug Market Trends
    Table 158. Rotavirus Infections Drug Market Drivers
    Table 159. Rotavirus Infections Drug Market Challenges
    Table 160. Rotavirus Infections Drug Market Restraints
    Table 161. Research Programs/Design for This Report
    Table 162. Key Data Information from Secondary Sources
    Table 163. Key Data Information from Primary Sources
List of Figures
    Figure 1. Rotavirus Infections Drug Product Picture
    Figure 3. Global Rotavirus Infections Drug Market Share by Type in 2021 & 2028
    Figure 3. RV-3BB Product Picture
    Figure 4. RV-625 Product Picture
    Figure 5. UMN-2001 Product Picture
    Figure 6. Rotavac-5C Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Rotavirus Infections Drug Market Share by Application in 2021 & 2028
    Figure 9. Clinic
    Figure 10. Hospital
    Figure 11. Others
    Figure 12. Rotavirus Infections Drug Report Years Considered
    Figure 13. Global Rotavirus Infections Drug Sales 2017-2028 (K Pcs)
    Figure 14. Global Rotavirus Infections Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Rotavirus Infections Drug Revenue 2017-2028 (US$ Million)
    Figure 16. Global Rotavirus Infections Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Rotavirus Infections Drug Sales Market Share by Region (2017-2022)
    Figure 18. Global Rotavirus Infections Drug Sales Market Share by Region (2023-2028)
    Figure 19. North America Rotavirus Infections Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 20. North America Rotavirus Infections Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Rotavirus Infections Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 22. Europe Rotavirus Infections Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Rotavirus Infections Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 24. Asia-Pacific Rotavirus Infections Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Rotavirus Infections Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 26. Latin America Rotavirus Infections Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Rotavirus Infections Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 28. Middle East & Africa Rotavirus Infections Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Rotavirus Infections Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Rotavirus Infections Drug in the World: Market Share by Rotavirus Infections Drug Revenue in 2021
    Figure 31. Global Rotavirus Infections Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Rotavirus Infections Drug Sales Market Share by Type (2017-2028)
    Figure 33. Global Rotavirus Infections Drug Revenue Market Share by Type (2017-2028)
    Figure 34. Global Rotavirus Infections Drug Sales Market Share by Application (2017-2028)
    Figure 35. Global Rotavirus Infections Drug Revenue Market Share by Application (2017-2028)
    Figure 36. North America Rotavirus Infections Drug Sales Market Share by Type (2017-2028)
    Figure 37. North America Rotavirus Infections Drug Revenue Market Share by Type (2017-2028)
    Figure 38. North America Rotavirus Infections Drug Sales Market Share by Application (2017-2028)
    Figure 39. North America Rotavirus Infections Drug Revenue Market Share by Application (2017-2028)
    Figure 40. North America Rotavirus Infections Drug Sales Share by Country (2017-2028)
    Figure 41. North America Rotavirus Infections Drug Revenue Share by Country (2017-2028)
    Figure 42. U.S. Rotavirus Infections Drug Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Rotavirus Infections Drug Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Rotavirus Infections Drug Sales Market Share by Type (2017-2028)
    Figure 45. Europe Rotavirus Infections Drug Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Rotavirus Infections Drug Sales Market Share by Application (2017-2028)
    Figure 47. Europe Rotavirus Infections Drug Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Rotavirus Infections Drug Sales Share by Country (2017-2028)
    Figure 49. Europe Rotavirus Infections Drug Revenue Share by Country (2017-2028)
    Figure 50. Germany Rotavirus Infections Drug Revenue (2017-2028) & (US$ Million)
    Figure 51. France Rotavirus Infections Drug Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Rotavirus Infections Drug Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Rotavirus Infections Drug Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Rotavirus Infections Drug Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Rotavirus Infections Drug Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Rotavirus Infections Drug Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Rotavirus Infections Drug Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Rotavirus Infections Drug Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Rotavirus Infections Drug Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Rotavirus Infections Drug Revenue Share by Region (2017-2028)
    Figure 61. China Rotavirus Infections Drug Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Rotavirus Infections Drug Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Rotavirus Infections Drug Revenue (2017-2028) & (US$ Million)
    Figure 64. India Rotavirus Infections Drug Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Rotavirus Infections Drug Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Rotavirus Infections Drug Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Rotavirus Infections Drug Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Rotavirus Infections Drug Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Rotavirus Infections Drug Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Rotavirus Infections Drug Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Rotavirus Infections Drug Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Rotavirus Infections Drug Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Rotavirus Infections Drug Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Rotavirus Infections Drug Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Rotavirus Infections Drug Sales Share by Country (2017-2028)
    Figure 76. Latin America Rotavirus Infections Drug Revenue Share by Country (2017-2028)
    Figure 77. Mexico Rotavirus Infections Drug Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Rotavirus Infections Drug Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Rotavirus Infections Drug Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Rotavirus Infections Drug Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Rotavirus Infections Drug Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Rotavirus Infections Drug Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Rotavirus Infections Drug Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Rotavirus Infections Drug Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Rotavirus Infections Drug Revenue Share by Country (2017-2028)
    Figure 86. Turkey Rotavirus Infections Drug Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Rotavirus Infections Drug Revenue (2017-2028) & (US$ Million)
    Figure 88. UAE Rotavirus Infections Drug Revenue (2017-2028) & (US$ Million)
    Figure 89. Rotavirus Infections Drug Value Chain
    Figure 90. Rotavirus Infections Drug Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Beijing Minhai Biotechnology Co Ltd
Bharat Biotech International Ltd
Biological E Ltd
Curevac AG
Medicago Inc
Nanotherapeutics Inc
Serum Institute of India Ltd
UMN Pharma Inc
Wuhan Institute of Biological Products Co Ltd
Frequently Asked Questions
Rotavirus Infections Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Rotavirus Infections Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Rotavirus Infections Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Vitiligo Drug

Vitiligo Drug market is segmented by Type and by Application. Players, stakeholders, and other pa ... Read More

Aurora Kinase C

Aurora Kinase C market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More

Transthyretin

Transthyretin market is segmented by Type and by Application. Players, stakeholders, and other pa ... Read More